Rituximab in the treatment of refractory or relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome). [electronic resource]
Producer: 20140804Description: R133 p. digitalISSN:- 1478-6362
- Adult
- Antibodies, Antineutrophil Cytoplasmic -- blood
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- B-Lymphocyte Subsets -- drug effects
- C-Reactive Protein -- metabolism
- Churg-Strauss Syndrome -- blood
- Drug Resistance
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin E -- blood
- Immunosuppressive Agents -- therapeutic use
- Lymphocyte Count
- Male
- Middle Aged
- Recurrence
- Retrospective Studies
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.